Abstract
Treatment of cutaneous leishmaniasis depends on drugs that potentially cause serious side effects and resistance. Thus, topical therapies are attractive alternatives to the drugs currently used. 3β, 6β, 16β-trihydroxylup-20 (29)-ene is a lupane triterpene isolated fromCombretum leprosumMart. leaves (CLF-1), with reports ofin vitroantileishmanial effect againstL.amazonensisand to promote lesion healing in animal model. Herein, we evaluated thein vitroandin vivoantileishmanial and healing effects of CLF-1 againstL.braziliensis. CLF-1 treatment showed low toxicity in macrophages and significantly reduced parasite loadin vitro. CLF-1 induced higher IL-12 and TNF-α production and more discrete IL-4 and IL-10 production. Forin vivoevaluation, a CLF-1 cream formulation was prepared to treat hamsters infected withL.braziliensis. CLF-1 treatment was able to reduce parasite load of the infected skin and lymph node more efficiently than the conventional treatment. Histopathological analysis indicated a strong inflammatory response accompanied by an important healing response. Data from this study indicate that topical CLF-1 treatment was effective and non-toxic inL.braziliensisinfected hamsters suggesting its potential for further development as a future therapeutic intervention.
Publisher
Public Library of Science (PLoS)